KemPharm to Report Third Quarter 2019 Results
Conference Call and Live Audio Webcast with Slide Presentation Scheduled forThursday, November 14, 2019, 5:30 p.m. ETCELEBRATION, Fla., Nov. 12, […]
VERB Launches LEARN, a New Education Feature In its Industry Leading CRM, Designed to Increase Knowledge, Retention and Brand Loyalty
NEWPORT BEACH, Calif. and SALT LAKE CITY, Nov. 12, 2019 (GLOBE NEWSWIRE) — VERB Technology Company, Inc. (NASDAQ: VERB; VERBW) […]
Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
WARREN, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics […]
Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of Repotrectinib in Pediatric Patients
SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel […]
Yield10 Bioscience Announces Third Quarter 2019 Financial Results
WOBURN, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company that uses its “Trait […]
NextCure Reports Third Quarter 2019 Financial Results
BELTSVILLE, Md., Nov. 12, 2019 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]
Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
– Presentation with live audio webcast on Wednesday, November 20th at 5:20 PM DST –Norwood, MA , Nov. 12, 2019 […]
Celldex Provides Corporate Update and Reports Third Quarter 2019 Results
HAMPTON, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the […]
LogicBio Reports Third Quarter 2019 Financial Results and Provides Business Updates
CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a genome editing company […]
LHC Group to Present at Stephens Nashville Investment Conference
LAFAYETTE, La., Nov. 12, 2019 (GLOBE NEWSWIRE) — LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting […]
